CEMI:CA:TSX-CIBC Emerging Markets Equity Index ETF (CAD)

ETF | Others |

Last Closing

CAD 19.6

Change

0.00 (0.00)%

Market Cap

CAD 0.09B

Volume

1.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.73 (+2.17%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.08 (+0.27%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.70 (-2.76%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+1.09 (+3.06%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.01%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.59 (-2.03%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.10 (-0.91%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.03 (-0.13%)

CAD 2.78B

ETFs Containing CEMI:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.82% 77% C+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.82% 76% C+ 64% D
Trailing 12 Months  
Capital Gain 8.71% 64% D 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.71% 58% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.36% 46% F 43% F
Dividend Return 2.46% 41% F 34% F
Total Return 0.10% 13% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 9.42% 53% F 75% C
Risk Adjusted Return 26.08% 37% F 41% F
Market Capitalization 0.09B 62% D 33% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.